Baxion
Screening
Tags
Alerts
Theme
Proqr Therapeutics N.V.
PRQR
·
NASDAQ
·
$1.57
Share Price as of 11/2
·
$165M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
03/12/26
20-F
Annual report (foreign)
03/13/25
20-F
Annual report (foreign)
03/13/24
20-F
Annual report (foreign)
03/29/23
20-F
Annual report (foreign)
04/29/22
Disclosures
Filter
6-K/A
Foreign issuer report (amended)
10/30/26
6-K
Foreign issuer report
10/28/26
6-K
Foreign issuer report
09/23/26
6-K
Foreign issuer report
09/09/26
6-K
Foreign issuer report
08/13/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
07/15/26
F-3
Shelf registration (foreign)
07/06/26
424B5
Prospectus supplement
06/26/26
424B5
Prospectus supplement
03/25/25
F-3
Shelf registration (foreign)
03/13/25
Proxies
Filter
No matching filings.
Ownership
Filter
Form 4
Insider transaction
08/03/26
SC 13D/A
Beneficial ownership (amended)
07/29/26
SC 13G
Beneficial ownership
07/29/26
SC 13G/A
Beneficial ownership (amended)
07/24/26
Form 4
Insider transaction
07/21/26
Other
Filter
EFFECT
Request for effectiveness
07/15/26
EFFECT
Request for effectiveness
03/25/25
CORRESP
Correspondence with the SEC
03/21/25
UPLOAD
Letter from the SEC
03/20/25
EFFECT
Request for effectiveness
10/10/24
Latest Filings
Filter
6-K/A
Foreign issuer report (amended)
10/30/26
6-K
Foreign issuer report
10/28/26
6-K
Foreign issuer report
09/23/26
6-K
Foreign issuer report
09/09/26
6-K
Foreign issuer report
08/13/26
Ownership
Filter
Form 4
Insider transaction
08/03/26
SC 13D/A
Beneficial ownership (amended)
07/29/26
SC 13G
Beneficial ownership
07/29/26
SC 13G/A
Beneficial ownership (amended)
07/24/26
Form 4
Insider transaction
07/21/26